文献速递肾移植

肾移植活检中抗体介导排斥相关转录本的诊断应用

Diagnostic application of transcripts associated with antibody-mediated rejection in kidney transplant biopsies.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

本研究基于297例肾移植活检回顾性队列,用实时定量PCR检测10个AMR相关基因,评估基因表达评分作为AMR诊断标准的应用价值。结果显示,在疑似AMR但未完全满足诊断标准的活检中,高基因评分者移植物丢失风险显著更高,且基因评分可改善该亚组的风险分类。

要点

  • 10基因AMR评分可识别疑似AMR活检中移植物丢失高风险者。
  • 在AMRsusp组,基因评分与移植物丢失风险独立相关。
  • 基因评分仅在AMRsusp组改善风险分类,全队列未见此效应。

核心结论

  • 与AMR强相关的基因评分有助于识别疑似AMR但未完全满足诊断标准的活检中移植物丢失高风险病例。

研究设计与样本

  • 回顾性队列研究,纳入297例肾移植活检,采用实时定量PCR检测10个AMR相关基因。
  • 活检分为AMR组(n=27)、疑似AMR组(AMRsusp,n=49)和无AMR组(No-AMR,n=221)。

主要发现

  • AMRsusp组中16例高评分者移植物存活显著差于33例低评分者。
  • AMRsusp组中,AMR 10基因评分与移植物丢失风险升高显著相关(单变量HR=1.109,P=0.004;多变量HR=1.138,P=0.012)。
  • 全队列中,AMR 10基因评分与移植物丢失风险无显著关联。
  • 在AMRsusp组中,将基因评分加入组织学和血清学数据后,净重分类指数和综合判别改善分析分别显示风险分类改善和判别能力提高,但全队列未见此改善。

临床怎么用

  • 对于疑似AMR但未完全满足Banff诊断标准的肾移植活检,可考虑检测10基因AMR评分以辅助风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The diagnosis of antibody-mediated rejection (AMR) is reached using the Banff Classification for Allograft Pathology, which now includes gene expression analysis. In this study, we investigate the application of 'increased expression of thoroughly validated gene transcripts/classifiers strongly associated with AMR' as diagnostic criteria. METHOD: We used quantitative real-time polymerase chain reaction for 10 genes associated with AMR in a retrospective cohort of 297 transplant biopsies, including biopsies that met the full diagnostic criteria for AMR, even without molecular data (AMR, n = 27), biopsies that showed features of AMR, but that would only meet criteria for AMR with increased transcripts [suspicious for AMR (AMRsusp), n = 49] and biopsies that would never meet criteria for AMR (No-AMR, n = 221). RESULTS: A 10-gene AMR score trained by a receiver-operating characteristic to identify AMR found 16 cases with a high score among the AMRsusp cases (AMRsusp-high) that had significantly worse graft survival than those with a low score (AMRsusp-low; n = 33). In both univariate and multivariate Cox regression analysis, the AMR 10-gene score was significantly associated with an increased hazard ratio (HR) for graft loss (GL) in the AMRsusp group (HR = 1.109, P = 0.004 and HR = 1.138, P = 0.012, respectively), but not in the whole cohort. Net reclassification index and integrated discrimination improvement analyses demonstrated improved risk classification and superior discrimination, respectively, for GL when considering the gene score in addition to histological and serological data, but only in the AMRsusp group, not the whole cohort. CONCLUSIONS: This study provides evidence that a gene score strongly associated with AMR helps identify cases at higher risk of GL in biopsies that are suspicious for AMR but do not meet full criteria.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Toulza F, Dominy K, Willicombe M, et al. Diagnostic application of transcripts associated with antibody-mediated rejection in kidney transplant biopsies. Nephrol Dial Transplant. 2022. PMID: 34320215. doi:10.1093/ndt/gfab231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。